Bone Scintigraphy and SPECT/CT of Bisphosphonate-Induced Osteonecrosis of the Jaw

被引:70
作者
Dore, Franca [1 ]
Filippi, Luca [1 ]
Biasotto, Matteo [2 ]
Chiandussi, Silvia [2 ]
Cavalli, Fabio [3 ]
Di Lenarda, Roberto [2 ]
机构
[1] Hosp Maggiore Trieste, Nucl Med Sect, Trieste, Italy
[2] Univ Trieste, Sect Dent Sci, Trieste, Italy
[3] Hosp Maggiore Trieste, Sect Radiodiagnost Imaging, Trieste, Italy
关键词
bone scintigraphy; SPECT/CT; jaw; osteonecrosis; EMISSION-TOMOGRAPHY; SKELETAL LESIONS; RISK-FACTORS; CANCER; CT; ASSOCIATION;
D O I
10.2967/jnumed.107.048785
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Endovenous bisphosphonate therapy seems associated with osteonecrosis of the jaw. The aim of this study was to evaluate the additional diagnostic value of hybrid SPECT/CT in (99m)Tc-methylene diphosphonate 3-phase bone scintigraphy of osteonecrosis of the jaw in bisphosphonate-treated patients. Methods: We studied 15 patients (12 women and 3 men) with extraoral tumors affected by lytic bone metastases and multiple myeloma. All patients were previously treated with intravenous bisphosphonates (zoledronic acid) for 1-3 y, were negative for dental disease at clinical examination, and had suspected osteonecrosis of the jaw. All 15 patients underwent panoramic x-ray orthopantomography, CT or MRI (or both), microbiologic examination, 3-phase bone scintigraphy, and SPECT/CT of the maxillary region. Results: Three-phase bone-scintigraphy showed increased perfusion and an increased blood pool in 9 of 12 and 10 of 12 patients, respectively; at the metabolic phase, SPECT was positive in all patients and showed abnormal hyperactivity in the maxilla of 2 patients, in the mandible of 9 patients, and in both the mandible and the maxilla of 4 patients. Hybrid SPECT/CT was of particular value in 8 of 15 patients, allowing discrimination of the osteonecrotic core from nearby hyperactivity due to viable bone. Whole-body scintigraphy showed remote and multiple metastases in all patients. Orthopantomography showed nonspecific bone rarefaction in all patients but was not able to aid diagnosis of osteonecrosis of the jaw. CT and MRI showed anomalies in all symptomatic patients: CT was helpful in evaluating both cortical and trabecular bone aspects, and MRI was able to detect soft-tissue involvement but not cortical bone destruction. Conclusion: In appropriately selected oncology patients treated with bisphosphonates, an increased uptake of (99m)Tc-methylene diphosphonate in maxillary bones may suggest probable osteonecrosis of the jaw. In such cases, SPECT/CT may be of value in increasing the diagnostic accuracy of bone scanning, providing a precise functional anatomic correlation for the definition of the extent of disease.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 18 条
[1]   COMPARATIVE-STUDY OF TC-99M BONE SCANS AND ORTHOPANTOMOGRAPHY IN DETERMINING MANDIBLE INVASION IN INTRAORAL SQUAMOUS-CELL CARCINOMA [J].
AHUJA, RB ;
SOUTAR, DS ;
MOULE, B ;
BESSENT, RG ;
GRAY, H .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1990, 12 (03) :237-243
[2]   Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases [J].
Bagan, JV ;
Murillo, J ;
Jimenez, Y ;
Poveda, R ;
Milian, MA ;
Sanchis, JM ;
Silvestre, FJ ;
Scully, C .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2005, 34 (02) :120-123
[3]   Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors [J].
Bamias, A ;
Kastritis, E ;
Bamia, C ;
Moulopoulos, LA ;
Melakopoulos, L ;
Bozas, G ;
Koutsoukou, V ;
Gika, D ;
Anagnostopoulos, A ;
Papadimitriou, C ;
Terpos, E ;
Dimopoulos, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8580-8587
[4]   Bisphosphonates and avascular necrosis of the jaw: a possible association [J].
Carter, G ;
Goss, AN ;
Doecke, C .
MEDICAL JOURNAL OF AUSTRALIA, 2005, 182 (08) :413-415
[5]   Therapy Insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease [J].
Dunstan, Colin R. ;
Felsenberg, Dieter ;
Seibel, Markus J. .
NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (01) :42-55
[6]  
Even-Sapir E, 2007, J NUCL MED, V48, P319
[7]   Evaluation of combined transmission and emission tomography for classification of skeletal lesions [J].
Horger, M ;
Eschmann, SM ;
Pfannenberg, C ;
Vonthein, R ;
Besenfelder, H ;
Claussen, CD ;
Bares, R .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (03) :655-661
[8]  
ISRAEL O, 1988, J NUCL MED, V29, P1341
[9]   SPECT/CT in tumor imaging: Technical aspects and clinical applications [J].
Keidar, Z ;
Israel, O ;
Krausz, Y .
SEMINARS IN NUCLEAR MEDICINE, 2003, 33 (03) :205-218
[10]   Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment [J].
Marx, RE ;
Sawatari, Y ;
Fortin, M ;
Broumand, V .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2005, 63 (11) :1567-1575